×
AI models easily absorb medical misinformation, study finds
Written by
Published on
Join our daily newsletter for breaking news, product launches and deals, research breakdowns, and other industry-leading AI coverage
Join Now

Large language models (LLMs) can be easily compromised with medical misinformation by altering just 0.001% of their training data, according to new research from New York University.

Key findings: Researchers discovered that injecting a tiny fraction of false medical information into LLM training data can significantly impact the accuracy of AI responses.

  • Even when misinformation made up just 0.001% of training data, over 7% of the LLM’s answers contained incorrect medical information
  • The compromised models passed standard medical performance tests, making the poisoning difficult to detect
  • For a large model like LLaMA 2, researchers estimated it would cost under $100 to generate enough misleading content to compromise its medical responses

Methodology breakdown: The research team focused on The Pile, a common LLM training database, examining how medical misinformation affects AI responses across different medical specialties.

  • Researchers selected 60 medical topics across general medicine, neurosurgery, and medications
  • They used GPT-3.5 to generate convincing medical misinformation by bypassing its safeguards
  • The team tested different percentages of false information to find the minimum amount needed to compromise the system

Technical implications: The study revealed several concerning vulnerabilities in how LLMs process and validate medical information.

  • Misinformation can be hidden in invisible webpage text or metadata that still gets incorporated into training data
  • Standard methods to improve model performance post-training proved ineffective at addressing the poisoned data
  • The compromised models showed degraded performance even on medical topics not directly targeted by the false information

Potential solutions: The researchers developed some promising approaches to combat medical misinformation in LLMs.

  • They created an algorithm that cross-references medical terminology against validated biomedical knowledge databases
  • This system successfully flagged a high percentage of medical misinformation for human review
  • However, the solution may not be practical for general-purpose LLMs used in search engines and other consumer applications

Broader challenges: The research highlights fundamental issues with medical information in AI systems that extend beyond intentional poisoning.

  • General-purpose LLMs trained on internet data are already exposed to significant medical misinformation
  • Even curated medical databases like PubMed contain outdated treatments and disproven research
  • The rapid evolution of medical knowledge means that maintaining accurate, up-to-date training data remains a significant challenge

Future implications: The ease of compromising medical AI systems raises serious concerns about their reliability and potential misuse.

  • The low cost and effort required to poison LLMs could incentivize bad actors to spread medical misinformation
  • As LLMs become more integrated into search engines and healthcare applications, ensuring their accuracy becomes increasingly critical
  • The challenge of creating trustworthy medical AI systems may prove even more complex than advancing medical science itself
It’s remarkably easy to inject new medical misinformation into LLMs

Recent News

Naqi unveils neural earbuds at CES to control devices with your brain

Neural earbuds that detect brain waves and subtle facial movements allow hands-free control of computers and smart devices without surgery.

DeepMind chief scientist calls for alternatives to prompt engineering

Prompt engineering dominates AI use, but Google DeepMind's principal scientist critiques it as an unreliable and temporary solution, calling for intuitive alternatives.

75 AI discovered molecules are entering clinical trials

AI tools are revolutionizing drug discovery, with 75 AI-designed molecules entering clinical trials and companies like Insilico Medicine cutting development timelines from years to months.